Hologic ao Showcase queMudam a tecnologia de Tomosynthesis do peito e às outras inovações de produto no ECR
Press releases may be edited for formatting or style | February 28, 2013
Bedford, Mass., -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will display an extensive suite of healthcare solutions for breast cancer screening and diagnosis, breast biopsy, osteoporosis risk assessment, medical MRI coils, and extremity imaging at the annual meeting of the European Society of Radiology, in Vienna, Austria March 7 - 11. The European Congress of Radiology (ECR), the largest radiological meeting in Europe, annually attracts over 20,000 participants representing the medical specialty of radiology throughout Europe and many other countries of the world.
"All eyes in the radiology community are on Vienna in March and the five-day European Congress of Radiology," said David Harding, Hologic's Senior Vice President and General Manager, International. "We believe this will be an exceptionally exciting time to reach out to the radiology world with our newest innovations in imaging. Of particular interest this year are advances in our breast tomosynthesis program, including the introduction of a tomosynthesis biopsy option for our Affirm breast biopsy guidance system. In addition, a significant number of peer-reviewed papers have been accepted by major scientific journals, including the recent publication of the results of the Oslo Breast Tomosynthesis Screening Trial. This and other publications continue to build support for the benefits of Hologic's breast tomosynthesis - improved accuracy compared to conventional mammography, resulting in earlier detection of cancers and a reduced need for recalls."
Hologic Is Offering Three Special Tomosynthesis-related Events at ECR:
--A special ECR Satellite Symposium, "Celebrating the Evolution of Tomosynthesis," on Saturday, March 9 from 2:00 to 3:30 p.m. in the Austria Center Vienna, Room C. The symposium will focus on:
The Oslo Tomosynthesis Screening Trial Results Per Skaane, Professor Dr. Med., Oslo University Hospital Ullevaal, Oslo, Norway
Initial Experience with Tomosynthesis-guided Biopsy - Dr. Daniela Bernardi, Division U.O. Senologia Clinica e Screening Mammografico, Dipartimento di Radioliagnostica, Trento, Italy
A Review of the Evolution of Breast Tomosynthesis - Andrew Smith, Ph.D., Hologic, Inc., Bedford, Mass., USA
--Nine 75-minute breast tomosynthesis education sessions from March 7th thru the 10th. Each session includes hands-on experience reading breast tomosynthesis images in combination with conventional and synthesized 2D images.
|
|
You Must Be Logged In To Post A Comment
|